Kathleen Moore, MD
Nebraska Medical Center · Obstetrics and Gynecology · University of Oklahoma
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kathleen Moore, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07737795 · Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial CancerUniversity of Oklahoma · not yet recruiting · Endometrial Cancer · principal investigator
- Ph2NCT03526432 · Phase II Study of Atezolizumab + Bevacizumab in Endometrial CancerUniversity of Oklahoma · active not recruiting · Endometrial Cancer · principal investigator
- Ph2NCT03476798 · Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or EndometriumUniversity of Oklahoma · completed · Cervical Cancer, Endometrial Cancer · principal investigator
- Ph1NCT03206177 · Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or OvaryUniversity of Oklahoma · completed · Carcinosarcoma, Ovarian · principal investigator
- Ph1NCT03206645 · Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant ChemotherapyUniversity of Oklahoma · completed · Ovarian Cancer · study chair
- Ph2NCT03189446 · Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial CancerUniversity of Oklahoma · completed · Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer · principal investigator
- Ph2NCT02272790 · Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerAstraZeneca · completed · Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation · principal investigator
- Ph3NCT01844986 · Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.AstraZeneca · active not recruiting · Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV · principal investigator
- Ph1NCT00666991 · Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal CancersCritiTech, Inc. · completed · Peritoneal Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Route 66 Endometrial Cancer SPOREP50CA265793 · NCI · WASHINGTON UNIVERSITY · PI DORIS Mangiaracina BENBROOK, Kimberly K. Leslie, David G Mutch · fiscal years 2023 to 2026Named on NCT07737795
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.